sameAs
A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial)Parkinson's disease dementia and dementia with Lewy bodies: different aspects of one entityEffectiveness and acceptability of non-pharmacological interventions to reduce wandering in dementia: a systematic reviewQuetiapine and rivastigmine and cognitive decline in Alzheimer's disease: randomised double blind placebo controlled trialPutting brain training to the test.Cognitive impairment in studies of 5HTTLPR and psychosis in Alzheimer's disease: a systematic reviewImproving quality of life for people with dementia in care homes: making psychosocial interventions workNeuropsychiatric symptoms in Alzheimer's disease: past progress and anticipation of the futureOptimised anaesthesia to reduce post operative cognitive decline (POCD) in older patients undergoing elective surgery, a randomised controlled trialEfficacy of memantine for agitation in Alzheimer's dementia: a randomised double-blind placebo controlled trialDiagnosis and management of dementia with Lewy bodies: third report of the DLB ConsortiumA systematic literature review of the effectiveness of non-pharmacological interventions to prevent wandering in dementia and evaluation of the ethical implications and acceptability of their use.Brief psychosocial therapy for the treatment of agitation in Alzheimer disease (the CALM-AD trial).Quantification of Alzheimer pathology in ageing and dementia: age-related accumulation of amyloid-beta(42) peptide in vascular dementia.Antidepressants and mortality risk in a dementia cohort: data from SveDem, the Swedish Dementia Registry.Neurocardiovascular instability in cognitive impairment and dementia.Cardiovascular effects of donepezil in patients with dementia.Carotid sinus syndrome is common in dementia with Lewy bodies and correlates with deep white matter lesions.Incidence and prediction of falls in dementia: a prospective study in older people.Clinical neurochemistry: developments in dementia research based on brain bank material.Reduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body DementiaDiagnosing dementia with Lewy bodies.Overlap between pathology of Alzheimer disease and vascular dementia.Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathologyCore outcome measures for interventions to prevent or slow the progress of dementia for people living with mild to moderate dementia: Systematic review and consensus recommendations.Neuropathological substrates of dementia and depression in vascular dementia, with a particular focus on cases with small infarct volumes.Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies.Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.Hypertension is a potential risk factor for vascular dementia: systematic review.Treatment effect of memantine on survival in dementia with Lewy bodies and Parkinson's disease with dementia: a prospective studyExploratory analysis of seven Alzheimer's disease genes: disease progressionIdentification of novel α-synuclein isoforms in human brain tissue by using an online nanoLC-ESI-FTICR-MS methodSalvia lavandulaefolia (Spanish sage) enhances memory in healthy young volunteers.Contrast sensitivity and visual acuity in patients with Alzheimer's disease.Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease.Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial.Neuropsychiatric aspects of Alzheimer's disease.Efficacy of memantine in PDD and DLB: an extension study including washout and open-label treatment.Stroke and cognition.Dementia with Lewy bodies: clinical features and treatment.
P50
Q21144654-FB53F1DE-1331-4E40-A32D-744FC9DB2BFEQ22251370-A1B95F83-F4B5-43E7-9041-596617969A7AQ22252905-A003A553-95CC-4869-974A-7689CF31A125Q24555726-89D7B6B9-EF63-4F7F-B19D-53BCD3E95306Q24594935-48481967-B9E1-4062-A9F1-03ADE150FB0DQ26830556-E3AE2B96-D74F-40A5-A2B5-DA998A40FF77Q26852895-0DA082BE-E5C3-491C-9C2B-70AD080843CBQ26864905-D6CBDEE9-2C5F-4963-A94F-A9571CEE9B48Q28728380-F5E7D9C9-1B68-41F7-8972-4D573469FD27Q28730154-D767D113-A1CB-4B45-88B8-A0E2C4C919D3Q29614409-15BD8421-8812-4276-8062-76330FA1FC8BQ30355577-2AB03E64-6F5F-4407-9D7B-9FA9A7BEB6FFQ30380032-C639A316-9475-47F3-906D-147ED7C2C958Q30813216-D4665095-E8F4-4F7E-945C-5F508CB1D3E3Q31126232-ACEB9D42-CE04-4A9F-B923-A5509E6999FEQ33148401-1C883372-F2FB-4C62-A00F-279063C57BA0Q33148671-4BF8BE4C-41DA-4B1E-A5F6-38A7B0FFA36BQ33151494-8644EEC5-9AD0-405E-9575-118A3588A965Q33444673-BA45350C-3FEA-4A10-A503-35ABB662C6F1Q33464724-D09D97D5-3524-4733-972A-2EC66681F31EQ33708946-06953E2C-03B0-428D-A62C-23DF9EE9306EQ33751527-4E5ECD26-A9D3-4A43-B8E8-326296BCEABEQ33803172-E4C3A589-6E07-432E-BBA6-FCBB69A9301FQ33822696-DA852C89-FE9F-4204-A84A-AFFB66E667F6Q33852962-83190AD2-4837-4D47-9DFE-468ED2BE4A0CQ33855557-32ED583D-21DF-4F9E-9416-FBEDDFA76958Q33864626-C35E0F1A-8493-4B2E-8F9C-C52C9C95B191Q33869820-6DD67439-E3EF-4519-BFA7-4499CE1CDFF1Q33873945-FD8535FD-9516-4F29-9928-B05DBC2816D6Q33879213-1FBDA324-0289-497E-86AD-189E7492C54FQ33897884-1D1D334D-7FF6-46F9-8C28-15681FFC5864Q33933189-0E661F2D-7621-451A-9040-D054E5CE8D76Q33967537-0A85701B-BD68-43BE-8189-E35CC3D0A95AQ33986104-28D6A82A-BE76-44E3-A135-E59F6A50CFD9Q33986104-B4A75650-EED4-4CA2-85B9-3A6BC5E70899Q33998388-895C0C77-2105-4797-950A-2065179C8BE8Q34018018-001E6C25-0D99-4EAA-B3CC-4E314F38826BQ34108175-328CFAD7-52A3-4358-B251-EB552515C924Q34128361-B36C89F5-377E-4247-953B-BB1B6E12E966Q34271990-5BAC7538-4024-41B5-A634-28482FBD5351
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Clive Ballard
@ast
Clive Ballard
@en
Clive Ballard
@es
Clive Ballard
@nl
Clive Ballard
@sl
type
label
Clive Ballard
@ast
Clive Ballard
@en
Clive Ballard
@es
Clive Ballard
@nl
Clive Ballard
@sl
altLabel
Ballard C
@en
Ballard CG
@en
C A Ballard
@en
C Ballard
@en
prefLabel
Clive Ballard
@ast
Clive Ballard
@en
Clive Ballard
@es
Clive Ballard
@nl
Clive Ballard
@sl
P108
P69
P1006
P214
P244
P1006
P108
P1153
35351371500
P21
P214
P244
P31
P4012
P496
0000-0003-0022-5632
P5008
P569
1964-01-01T00:00:00Z
P734
P735
P7859
lccn-n00008587